Skip to main content
Search
Sign in
Now unveilingUnveroLaunch home

The reveal · Research tools

EvidenceFlow logo

EvidenceFlow

Systematic review and meta-analysis platform for literature screening, data extraction, and evidence synthesis

  • 0community votes
  • 0DR by Ahrefs no change since last check

Ahrefs Domain Rating rehearsed 16 Nov 2026, recast 30 Oct 2026.

Free platform for systematic reviews, meta-analysis, and literature screening with optional paid AI-assisted features for screening, extraction, and manuscript

The story

Screenshot of the EvidenceFlow homepage
What evidenceflow.in looks like

EvidenceFlow is an AI-powered evidence synthesis platform designed for researchers, clinicians, and bioinformaticians conducting systematic reviews and meta-analyses. The core platform is free and includes literature import from PubMed, Scopus, RIS and BibTeX, automated deduplication, manual and AI-assisted screening with blind dual review, structured data extraction, meta-analysis with fixed and random effects pooling, PRISMA 2020 flow diagram generation, and team collaboration features. Paid AI-assisted features include relevance scoring and screening prioritization, extraction auto-fill, and manuscript drafting. The platform supports omics data integration for GWAS and RNA-seq analysis, generates publication-ready forest and funnel plots, and exports results as PDF, Word, Excel, CSV, and JSON.

Set list

  • Full-text screening with inclusion/exclusion criteria
  • Automated data extraction with AI auto-fill
  • Forest plots and funnel plots
  • Literature import from PubMed, Scopus, RIS, BibTeX, CSV

Pricing

Pricing model: Freemium

Free: Core platform with literature import, manual screening, extraction, meta-analysis, PRISMA 2020 flow diagrams, omics dashboard, report export, team collaboration, and 50 free AI actions. AI Assistant: ₹399/month, cancel anytime, includes AI-assisted screening, AI relevance scoring, AI extractio

Follow the tour. Log in to follow EvidenceFlow's tour

Follow EvidenceFlow to get an email when they post a milestone, ship a new product or add a demo video.

EvidenceFlow metrics

Reviews of evidenceflow.in's run: Ahrefs Domain Rating and Majestic link data, with the change since the last show.

  • 0 Domain Rating no change since last check
  • 0 Trust Flow no change since last check
  • 22 Citation Flow no change since last check
  • 11 Referring domains no change since last check
  • 18 External backlinks no change since last check

Ahrefs Domain Rating rehearsed 16 Nov 2026, recast 30 Oct 2026. Majestic rehearsed 30 Oct 2026, recast 30 Oct 2026. Link credits: Majestic. Trust Flow, Citation Flow and Topical Trust Flow are trademarks of Majestic-12 Ltd.

EvidenceFlow: the venue online

Show the venue details

Source: the public RDAP record, checked 15 Nov 2026, 22:27 UTC.

  • Domain age 2 months
  • Registered
  • Expires
  • Registrar HOSTINGER operations, UAB
  • DNSSEC Not signed

Backstage at evidenceflow.in

EvidenceFlow: the run since opening night

Measured after EvidenceFlow went live on Unvero Launch on 30 October 2026.
MeasureAt launch, then latest
Domain Rating (Ahrefs)0 to 0 no change since launch
30 Oct 2026, then 15 Nov 2026
Trust Flow (Majestic)0
first measured 30 Oct 2026
Referring domains (Majestic)11
first measured 30 Oct 2026

Day 17 since launch. Next receipt: day 30, 29 Nov 2026. A change here is a reading, not a claim about its cause; lots of things move these figures. Anything we do not measure is not shown.

Biggest gains on Unvero Launch

Got a launch coming up?

Free tips from Unvero Launch for getting ready, launch day, the week after and what to do next.

  • Get ready
  • Launch day
  • Week after
  • Afterwards

Read the launch playbook

Questions after the show

What is EvidenceFlow?
EvidenceFlow is an AI-assisted evidence synthesis platform for systematic reviews, meta-analysis, and omics research. It streamlines literature screening, structured data extraction, PRISMA 2020 reporting, and statistical analysis for researchers, clinicians, and bioinformaticians.
Is EvidenceFlow free to use?
The core platform is free with no time limit or seat restrictions, including literature import, manual screening, extraction, meta-analysis, PRISMA reporting, and reporting. AI-assisted screening, extraction auto-fill, and manuscript drafting are a paid upgrade at ₹399/month.
How does AI screening work in EvidenceFlow?
EvidenceFlow uses AI to prioritize studies based on your research question, PICO framework, and inclusion/exclusion criteria. Each study receives a suggested decision, confidence score, and explanation, while final screening decisions always remain under researcher control.
Can I collaborate with multiple reviewers?
Yes. EvidenceFlow supports multi-reviewer projects with role-based access, dual-reviewer screening, conflict detection, and an audit trail of every decision.
What statistical models are supported?
EvidenceFlow's meta-analysis engine supports both fixed-effect and random-effects pooling using DerSimonian–Laird methods, with heterogeneity statistics including Cochran's Q, I², and Tau², visualized as forest and funnel plots.

More on this profile

EvidenceFlow has a free listing. The owner can unlock the full profile with a paid launch for $5:

  • Founder story (locked)
  • Milestones (locked)
  • Demo video (locked)
  • Dofollow website link (locked)

Also on the bill

  1. Act 1

    Act 1: InsiderFilings.info logoInsiderFilings.info

    SEC insider filings screener for Forms 3, 4 and 5

    Research toolsGermanyStartupVerified

  2. Act 2

    Act 2: HackerTube AI logoHackerTube AI

    Curiosity, curated.

    Research toolsEstablished

    DR 11 +8 (up) since last check 0 votes. Log in to give HackerTube AI an encore vote
  3. Act 3

    Act 3: Innogath logoInnogath

    AI research workspace for cited reports, auto-generated diagrams, and branching knowledge pages

    Research tools

    DR 5 no change since last check 0 votes. Log in to give Innogath an encore vote
  4. Act 4

    Act 4: Peptide Titans logoPeptide Titans

    Research peptides with independent third-party testing and lot-specific documentation

    Research toolsUnited States

    DR 16 +1 (up) since last check 0 votes. Log in to give Peptide Titans an encore vote
Need help?